Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing focus towards accelerating drug development and cost reduction
3.2.1.2 Growing demand for real-time safety and efficacy monitoring of drugs and medical devices
3.2.1.3 Increasing adoption of RWE Solutions for informed reimbursement decision-making
3.2.1.4 Increasing adoption of data analytics services in clinical decision making
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of standardization in integration and interoperability of real-world data
3.2.2.2 Shortage of skilled professionals
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Component, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Services
5.3 Data sets
5.3.1 Disparate data sets
5.3.1.1 Clinical settings data sets
5.3.1.2 Claims data sets
5.3.1.3 Pharmacy data sets
5.3.1.4 Patient powered data sets
5.3.1.5 Registry-based data sets
5.3.2 Integrated data sets
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Drug development and approvals
6.2.1 Oncology
6.2.2 Cardiovascular disease
6.2.3 Neurology
6.2.4 Immunology
6.2.5 Other therapeutic areas
6.3 Medical device development and approvals
6.4 Post-market surveillance
6.5 Market access & reimbursement/coverage decision-making
6.6 Clinical & regulatory decision-making
Chapter 7 Market Estimates and Forecast, By Revenue Model, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pay-per-use (value-based pricing)
7.3 Subscription
Chapter 8 Market Estimates and Forecast, By Deployment Model, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 On-premise
8.3 Cloud-based
Chapter 9 Market Estimates and Forecast, By End User, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical and medical device companies
9.3 Healthcare payers
9.4 Healthcare providers
9.5 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 UAE
10.6.3 Saudi Arabia
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Aetion, Inc.
11.2 Cognizant Technology Solutions Corporation
11.3 Elevance Health, Inc.
11.4 Fortrea Inc.
11.5 ICON plc.
11.6 IQVIA Holdings Inc.
11.7 Merative
11.8 Optum, Inc.
11.9 Oracle Corporation
11.10 Parexel International Corporation
11.11 PerkinElmer Inc.
11.12 SAS Institute Inc.
11.13 Syneos Health, Inc.
11.14 Thermo Fisher Scientific Inc.
11.15 TriNetX LLC
